Categories
Marijuana

Supreme Cannabis Inc (OTCMKTS:SPRWF) Announces Blissco’s Latest Achievement

Supreme Cannabis Inc (OTCMKTS:SPRWF) is quite pleased with the latest major step made by its subsidiary Blissco Cannabis Corp. Since its acquisition; this premium wellness brand has focused its efforts and funds into maximizing the production of its cannabis oils. Supreme Cannabis congratulates Blissco for satisfying the conditions and standards set by the regulatory body Health Canada and eventually receiving an oil sales license.

Importance of the license

This license will enable the company to fully focus on the sale of full-spectrum cannabidiol (CBD) oil products. Blissco runs most of its business activities from its facility situated in Langley, British Columbia. Supreme Cannabis has been a major supporter of Blissco’s legacy of premium whole flower products since it acquired it.

 The growing unmet demand for top-quality CBD oil products in Canada requires the company to boost its production capacity. It has been doing a lot ranging from the construction of extraction facilities and labs to offering proper business guidelines. The construction of a large-scale ethanol-based extraction lab will be a costly undertaking. However, Supreme Cannabis has vowed to support the move.

Plans moving forward

Blissco says that it has plans underway to construct an even bigger facility to enable increased CO2-based extraction capability. A person well conversant with the matter, but who wanted his identity kept anonymous has spoken about the facility. According to him, the facility under construction will have the capacity to produce about 7,000,000 tincture bottles every year.

The CEO of Supreme Cannabis Navdeep Dhaliwal promises consumers of the company’s products that they have betters plans for them. These consumers will enjoy the benefits of the top-quality CBD oil products that the premium wellness brand will sell them. Blissco will be counting on its sophisticated expertise of its team to deliver the best products to customers. The hard work of the employees is what has gotten the company and its subsidiary to high success levels.

Asides from introducing its first CBD oil product, Blissco also promises to unveil some other complementary cannabis extract products. It will be doing this in the subsequent quarters.

There is also another interesting announcement. Todd McAdam is going to serve as the new General Manager of the Facility, as was revealed by Supreme Cannabis. He is an experienced professional who has worked in several food and beverage industries for over 30 years.

Categories
Marijuana

Supreme Cannabis Inc (OTCMKTS:SPRWF) Subsidiary To Receives Approval To Gain 50,000 Sqft Expansion

7ACRES, a subsidiary of Supreme Cannabis Inc (OTCMKTS:SPRWF), has received the approval of Health Canada for five additional flowering rooms. Supreme Cannabis made the announcement today outlining that the Ontario facility has been expanded by 50,000 sqft. The additional space will be important towards boosting the production capacity.

Details about the expansion

An official working at 7ACRES says that the expansion of flowering room space is from 180,000 sqft to 230,000 sqft. He adds that the estimated annual production will scale up from approximately 26,250kg to 33,580kg.

Supreme Cannabis hopes to witness further production efficiencies and it attributes that to the licensing of all 25 flowering rooms. The company projects that 7ACRES might be able to produce about 50,000kg.

The President and Founder of Supreme Cannabis John Fowler opines, “With five more flowering rooms at 7ACRES now approved by Health Canada, the finish line is in sight”.

The official adds that 7ACRES is currently working towards attaining full production capacity. If all moves according to plan, it might be able to fulfill the demand of the company’s top-notch cannabis.

Major developments in the course of this year

Supreme Cannabis has in the course of this year made other tremendous steps in business. The company unveiled Cambium Plant Sciences in Goderich, Ontario. Cambium is one of its wholly-owned subsidiaries and it will focus on revolutionizing the agricultural cannabis genetics. Asides from that, it will all work to redefine the cultivation economics and consumer experiences across the global cannabis industry.

Cambium focuses on the systematic application of technology, research, and science in its undertakings. It seeks to develop the next generation of premium cannabis genetics for medical, recreational and wellness applications. The subsidiary’s innovative mission is to serve the fast growing global cannabis market with the agriculturally-focused, disease resistant, premium seed stock.

The General Manager of Cambium Dr. Alan Darlington is optimistic that Cambium will make an important addition to the cannabis industry. He says that will be possible because they intend to revolutionize strain development. This move will enable them to enhance the wider industry’s outputs.

Supreme Cannabis says it has already set aside $14 million for the set up of a cannabis-focused facility. It will focus on cannabis research and innovation.

Categories
Marijuana

Supreme Cannabis Company Inc (OTCMKTS:SPRWF) Secures Health Canada’s Approval For Higher Production Capacity At 7ACRES Facility

Supreme Cannabis Company Inc (OTCMKTS:SPRWF) closed Friday’s trading session at $1.53 following the announcement that its subsidiary 7ACRES received Health Canada’s approval to carry out production activities at Kincardine, Ontario.

The announcement revealed that Health Canada has allowed 7ACRES to start cultivating on an extra 30,000 sqft of space at its Kincardine facility in Ontario. The additional permitted working area will increase the company’s total flowering space at 7ACRES to 120,000 sqft from 90,000 sqft. This means that the company’s yearly production capacity will also rise and the company expects it to grow from roughly 13.3 tons to 17.5 tons.

7ACTRES predicts that its production facility will produce roughly 50,000 kg of cannabis annually if all its 25 flowering rooms are licensed. The company was also awarded a license approval for the production space that it has set aside for plant micropropagation. Supreme Cannabis plans to kick off cannabis micropropagation which will take place at the 7ACRES facility. Its goal is to try out extra agricultural services at the facility which has been earning a strong reputation due to its high-quality cannabis production.

“Scaling our 7ACRES facility is a top priority and today’s announcement is another significant step forward towards completing that goal,” stated Supreme Cannabis founder and President, John Fowler.

The licenses will allow Supreme Cannabis to expand its market share in Canada

The Supreme Cannabis founder also noted that the subsidiary’s branded dried flower has also received positive consumer reviews in the Canadian market. He also noted that the extra production capacity courtesy of Health Canada’s approval would allow the company to satisfy the growing demand for cannabis in the country.

Meanwhile, 7ACRES is still on track to complete the construction of all the flowering rooms in its facility by the end of March this year. The company also expects its extra flowering rooms to receive Health Canada’s regulatory approval sometime soon. Supreme Cannabis already has a strong portfolio that not only includes its cannabis portfolio, but it also has equity holdings as well as a partnership for long-term global distribution with Medigrow which is based in Lesotho. The deal between the two firms facilitates medical-grade cannabis oil exports.

Categories
MMJ

SUPREME PHARMACEUTIC (OTCMKTS:SPRWF) Looks To Capitalize On MMPR’s Promising Opportunity

Nashville, TN – SUPREME PHARMACEUTIC (OTCMKTS:SPRWF) is looking to take advantage of the promising opportunities available in Marihuana for Medical Purposes Regulations, which attracted a lot of attention from the investment community. The move comes on the heels of TWEED MARIJUANA (OTCMKTS:TWMJF) making a debut. Interestingly, more investments started to flow into the segment.

Purchase Of Facility

Supreme has acquired a facility of 342,000 square foot space in May 2014 and spent about $4 million towards capital to translate it into a high-tech hybrid facility of growing marijuana. It would also have space for R&D and security installations apart from growing controls and advanced automation.

Currently, the company is in the final stages of the licensing process from Canada as far as its plans to produce, as well as, sell a maximum of 24,000 kg of medical marijuana was concerned. It plans to do it from its 7 acre hybrid greenhouse facility every year. The company’s facility is in Kincardine, Ontario. Supreme said that it was able to complete upgrades of $4 million worth of facility until now. It is now awaiting Health Canada personnel to inspect pre-license inspection.

Interestingly, the company has been able to generate support from the local community. It included residents from the area, municipal administrators, and contractors. In fact, the support has allowed it to reach pre-licensing stage as quickly as possible.

Goals

Supreme indicated that if it could start getting the operations during the next few weeks, it would not only be able to generate meaningful revenue but also earns a profit next year. It indicated that its high caliber quality control, as well as, growing teams would help the production schedule to proceed on track. At the same time, it would also ensure that the end product was of high quality besides being affordable for medical purposes throughout Canada.

The company has also set its long-term goals of providing additional reasons for investors’ to consider the stock. Supreme indicated that it was necessary to make marijuana of high quality and at an affordable price.

Pin It on Pinterest